News 26 jun 2023 CSEM to establish a digital health research department in Bern CSEM’s digital health research department will be relocated to Bern, marking an important milestone in the expansion of digital health research i...
Affiliato del mese 09 jan 2023 Lyfegen HealthTech AG: la collaborazione con S-GE ci dona credibilità e fiducia Mentre nuove cure innovative come terapie cellulari e genetiche consentono di salvare vite, i costi delle cure possono essere ingenti, ovvero par...
News 27 nov 2020 Dottikon ES to build new production plant Dottikon ES is building a new chemical production plant for pharmaceutical active ingredients. To achieve this, an investment in the amount of 27...
Aktuell 21 mai 2024 InSphero spannt mit Genome Biologics zusammen Das Biotech-Unternehmen InSphero hat mit Genome Biologics eine Vereinbarung zur Vermarktung der 3D Cardiac Organoid Platform unterzeichnet. Die P...
Actualités 26 out 2022 Cordis va acquérir la medtech vaudoise MedAlliance pour USD 1,1 milliard Dans le cadre d’une transaction totale pouvant atteindre USD 1,135 milliard, MedAlliance a signé un accord de sortie avec Cordis, un leader mondi...
News 13 jun 2023 Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey German pharmaceutical giant Merck has celebrated the inauguration of its state-of-the-art Biotech Development Center in Corsier-sur-Vevey.
News 16 nov 2020 Synendos raises 20 million Swiss francs Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The Basel biotech will use the funds to advance ...
News 03 ago 2023 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...
Actualités 16 out 2023 Adiposs clôture l’essai clinique de phase I de son produit phare ImageBAT La biotech genevoise Adiposs jette une lueur d’espoir sur les perspectives du traitement du cancer et des soins aux patients avec la conclusion r...
News 04 abr 2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
Aktuell 27 nov 2020 Dottikon ES baut neue Produktionsanlage Dottikon ES wird eine neue chemische Produktionsanlage für Pharmawirkstoffe errichten. Dafür ist eine Investition von 275 Millionen Franken vorge...
News 29 set 2020 Monte Rosa Therapeutics banks 96 million US dollars The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful Series B financ...
News 26 jun 2023 Revolutionary mRNA vaccine against melanoma to be tested in Geneva Moderna's mRNA vaccine for melanoma will be tested at the Geneva University Hospitals in 2023. The vaccine, combined with immunotherapy, could si...
News 26 mai 2023 Researchers at Kantonsspital St.Gallen find new approach for brain tumors St.Gallen - An international team of scientists led by Kantonsspital St.Gallen have developed new research approaches to combat malignant brain t...
News 20 out 2020 VectivBio secures investments totaling 110 million dollars The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing investors. Wit...
Aktuell 02 mai 2022 Bionter erhält 3 Millionen Dollar an Investitionen Die Bionter AG hat in einer Frühfinanzierungsrunde 3 Millionen Dollar erhalten. Diese Finanzierung ermöglicht es Bionter, noch in diesem Jahr sei...
News 04 abr 2024 Indivi joins forces with Biogen Indivi and Biogen are cooperating on the development of digital biomarkers for Parkinson’s disease. To this end, the US biotech group is licensin...